Compare CATX & CRAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CATX | CRAN |
|---|---|---|
| Founded | 1983 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 497.9M | 472.3M |
| IPO Year | 2018 | N/A |
| Metric | CATX | CRAN |
|---|---|---|
| Price | $3.43 | $10.13 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $12.11 | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 89.6K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.96 | $9.90 |
| 52 Week High | $6.16 | $10.13 |
| Indicator | CATX | CRAN |
|---|---|---|
| Relative Strength Index (RSI) | 53.74 | 69.80 |
| Support Level | $2.85 | $9.97 |
| Resistance Level | $4.27 | N/A |
| Average True Range (ATR) | 0.19 | 0.01 |
| MACD | 0.08 | 0.00 |
| Stochastic Oscillator | 66.06 | 100.00 |
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
Crane Harbor Acquisition Corp II is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.